Format

Send to

Choose Destination
Lancet. 2007 Apr 14;369(9569):1287-1301. doi: 10.1016/S0140-6736(07)60601-1.

Autosomal dominant polycystic kidney disease.

Author information

1
Mayo Clinic College of Medicine, Rochester, MN, USA. Electronic address: torres.vicente@mayo.edu.
2
Mayo Clinic College of Medicine, Rochester, MN, USA.
3
Cliniques St Luc, Université Catholique de Louvain, Brussels, Belgium.

Abstract

Autosomal dominant polycystic kidney disease is the most prevalent, potentially lethal, monogenic disorder. It is associated with large interfamilial and intrafamilial variability, which can be explained to a large extent by its genetic heterogeneity and modifier genes. An increased understanding of the disorder's underlying genetic, molecular, and cellular mechanisms and a better appreciation of its progression and systemic manifestations have laid out the foundation for the development of clinical trials and potentially effective treatments.

PMID:
17434405
DOI:
10.1016/S0140-6736(07)60601-1
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center